Epitel
Epilog, based in Salt Lake City, US, provides a wearable seizure detection system for effective epilepsy management.
Founded
2017Epilog, based in Salt Lake City, US, provides a wearable seizure detection system for effective epilepsy management.
Epitel, based in Salt Lake City, US, was founded with the mission to revolutionize epilepsy management through innovative technology. The company's core product, REMI™, is a groundbreaking, wireless wearable seizure detection system that records long-term EEG data, providing individuals with epilepsy a reliable tool to monitor and manage their condition effectively. By leveraging advanced AI for event detection, Epitel aims to offer peace of mind and enhance the quality of life for people living with epilepsy.
Notable affiliated individuals and investors include leading neurologists and technology experts who have contributed to the development and refinement of the REMI™ system. Epitel has achieved significant milestones, including FDA clearance for its device and successful deployment in both healthcare facilities and ambulatory settings. The overall impact of Epitel's technology is profound, offering unprecedented accuracy and convenience in seizure monitoring, thereby empowering patients and healthcare providers with critical insights for better epilepsy management.
Companies similar to Epitel include EpiWatch, Epalex, EnlitenAI and Empatica.
Epitel was founded in 2017.
Epitel's headquarters is located in Salt Lake City, UT, US.
Epitel's most recent funding round was for $12.5M (USD) in February 2022.
As of Feb 16, 2022, Epitel has disclosed funding of $20.4M (USD). Undisclosed round amounts are excluded.
Epitel has 37 employees as of Feb 4, 2024.
Empatica
empatica.com
